Agios Pharmaceuticals AGIO Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $113.6M+43.9% | $89.13M+16.9% | $92.71M-63.5% | $80.87M-4.3% | $78.96M-33.5% | ||
| $623.44M-23.4% | $765.3M-6.4% | $860.15M+14.5% | $858.07M+76.8% | $814.41M+69.9% | ||
| $16.13M+382% | $10.58M+157% | $5.03M+61.3% | $4.99M+32.5% | $3.34M-3.2% | ||
| $35.09M+18.5% | $32.92M+19.2% | $32.03M+21.2% | $30.85M+28.9% | $29.61M+28.3% | ||
| $834.84M-13.8% | $942.05M-2.4% | $1.03B-3.8% | $1.02B+61.3% | $968.62M+46.0% | ||
| $10.57M-4.5% | $10.78M-7.7% | $10.68M-9.7% | $10.58M-16.9% | $11.07M-21.6% | ||
| $1.18B-23.8% | $1.3B-22.0% | $1.39B-22.7% | $1.47B+90.3% | $1.56B+83.1% | ||
| $13.75M+0.2% | $18.36M+10.3% | $19.55M+14.1% | $17.53M+74.7% | $13.73M+23.0% | ||
| $58.85M+12.4% | $82.21M+1.3% | $74.76M-37.4% | $70.41M+12.4% | $52.37M+1.3% | ||
| $75.88M-14.7% | $104.11M-14.8% | $101.38M-38.6% | $101.68M-9.7% | $88.99M-15.9% | ||
| $76K+2.7% | $75K+2.7% | $74K+1.4% | $74K+1.4% | $74K+1.4% | ||
| -$660.82M-177% | -$561.71M-277% | -$453.67M-766% | -$350.23M+65.0% | -$238.21M+73.7% | ||
| $1.11B-24.4% | $1.19B-22.6% | $1.28B-21.0% | $1.37B+107% | $1.47B+97.1% | ||
| $1.18B-23.8% | $1.3B-22.0% | $1.39B-22.7% | $1.47B+90.3% | $1.56B+83.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Agios Pharmaceuticals's total assets?
- Agios Pharmaceuticals (AGIO) holds $1.2B in total assets, down 23.8% year over year.
- How much debt does Agios Pharmaceuticals have?
- Agios Pharmaceuticals carries $35.7M in total debt against $1.1B of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Agios Pharmaceuticals have?
- Agios Pharmaceuticals holds $113.6M in cash and equivalents.
- Can Agios Pharmaceuticals cover its short-term obligations?
- Its current ratio is 14.19 — current assets exceed current liabilities.
- Where does Agios Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
